Clinical Trial Update: Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy of intravenous immunoglobulin (IgIV) in patients with IgG subclass deficiency and recurrent infections has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Igg Subclass Deficiency
• Infections

Drugs mentioned

• IgIV (intravenous immunoglobulin) (intravenous immunoglobulin (IVIG))

Snippet

Sponsor: The Center for Rheumatic Disease, Allergy, & Immunology | Conditions: IgG Deficiency, Infections | Phase 2 | Status: COMPLETED